Clicks Group Limited · JSE:CLS
Clicks — FY2013 Earnings Presentation
33 slides from Clicks's earnings presentation, October 2013
Slide 1: Annual Results for the Year Ended 31 August 2013
ANNUAL RESULTS FOR THE YEAR ENDED 31 AUGUST 2013
Slide 2: Presentation Outline
PRESENTATION OUTLINE Review of the year Financial results Trading performance Outlook Questions CLICKS GROUP ANNUAL RESULTS 2013 2
Slide 3: Review of the Year
REVIEW OF THE YEAR DAVID KNEALE
Slide 4: Review of the Year
REVIEW OF THE YEAR Middle income consumers remain under pressure Minimal real growth in private healthcare market Health and beauty markets continue to be promotionally driven Selling price inflation constrained Better second half performance in Clicks UPD total turnover managed up 43.9%
Slide 5: Financial Results
FINANCIAL RESULTS MICHAEL FLEMING
Slide 6: Financial Highlights
FINANCIAL HIGHLIGHTS Group turnover up 13.6% Clicks turnover up 8.6% UPD turnover up 22.8% Selling price inflation of 2.6% Operating margin down from 6.6% to 6.3% Diluted headline EPS up 9.2% to 298.6 cps Cash generated by operations R1.4 billion Total dividend of 168.0 cps, up 10.5%
Slide 7: Turnover
TURNOVER % same R’m % % 2013 2012 change store inflation growth Clicks 11 293 10 401 8.6 5.8 3.1 Musica 862 872 (1.0) 5.9 2.6 The Body Shop 137 123 11.3 6.3 2.2 Total retail 12 292 11 396 7.9 5.8 3.1 UPD 7 710 6 277 22.8 1.8 Intragroup turnover (2 459) (2 236) 10.0 Total group 17 543 15 437 13.6 2.6
Slide 8: Total Income
TOTAL INCOME 2013 2012 % 2013 2012 R’m R’m change % margin % margin Retail 4 097 3 764 8.9 33.3 33.0 Distribution 655 559 17.1 8.5 8.9 Intragroup (56) (47) Total group 4 696 4 276 9.8 26.8 27.7 Private label margin growth and well managed promotional activity in Clicks UPD margin impacted by sup
Slide 9: Operating Expenditure - Retail
OPERATING EXPENDITURE - RETAIL R’m 2013 2012 % change Depreciation and amortisation 181 155 16.9 Occupancy costs 495 468 5.8 Employment costs 1 605 1 425 12.6 Other operating costs 910 863 5.5 Total retail costs 3 191 2 911 9.6 Continuing investment in stores and IT Pharmacy professional costs u
Slide 10: Operating Expenditure - Distribution
OPERATING EXPENDITURE - DISTRIBUTION R’m 2013 2012 % change Depreciation and amortisation 19 17 16.3 Occupancy costs 7 5 36.2 Employment costs 185 157 17.7 Other operating costs 249 224 11.2 Total distribution costs 460 403 14.3 Additional variable bulk distribution costs Temporary warehouse cos
Slide 11: Operating Profit
OPERATING PROFIT 2013 2012 % 2013 2012 R’m R’m change % margin % margin Retail 907 852 6.3 7.4 7.5 Distribution 195 157 24.2 2.5 2.5 Intragroup 2 2 Total group 1 104 1 011 9.1 6.3 6.6 Margins within target ranges, despite investment in pharmacy and UPD distribution Group margin impacted by mix C
Slide 12: Inventory
INVENTORY Days in stock* Inventory (R’m) 2013 2012 2013 2012 % change Retail 68 69 1 613 1 522 6.0 Distribution 30 34 619 567 9.0 Intragroup inventory (7) (9) Total group 59 63 2 225 2 080 7.0 UPD inventory normalised with annualisation of preferred supply contract Inventory growth contained bel
Slide 13: Cash Generation
CASH GENERATION R’m 2013 2012 Profit before tax 1 051 958 Non-cash adjustments 300 277 Operating profit before working capital changes 1 351 1 235 Working capital changes 26 (161) Net interest and tax paid (364) (310) Cash inflow from operations 1 013 764 32.6% increase in cash from operations CLI
Slide 14: Cash Utilisation
CASH UTILISATION R’m 2013 2012 Cash inflow from operations 1 013 764 Capital expenditure (310) (256) Dividends paid (394) (337) Share buy-backs (354) (12) Other investing activities 5 8 Other financing activities 130 (159) Net cash generated 90 8 CLICKS GROUP ANNUAL RESULTS 2013 14
Slide 15: Capital Management
CAPITAL MANAGEMENT Group will remain cash generative Investing in the business – R338m capex planned in FY2014 R182m stores R88m IT systems R38m UPD R30m other Return balance of cash to shareholders Dividend cover 1.8 times Continued share buy-backs CLICKS GROUP ANNUAL RESULTS 2013
Slide 16: Medium-Term Financial Targets
MEDIUM-TERM FINANCIAL TARGETS 2013 – 2015 Achieved 2014 – 2016 target in 2013 target ROE (%) 55 – 65 55.6 50 – 60 ROA (%) 14 – 18 14.8 14 – 18 Inventory days 55 – 60 59 55 – 60 Group operating margin (%) 6.0 – 7.0 6.3 6.0 – 7.0 Retail 7.0 – 8.0 7.4 7.0 – 8.0 UPD 2.2 – 2.7 2.5 2.2 – 2.7 CLICKS GROUP
Slide 17: Trading Performance
TRADING PERFORMANCE DAVID KNEALE
Slide 18: Sales Performance
SALES PERFORMANCE % change % contribution Pharmacy 10.8 25.9 Front shop health 15.9 21.7 Beauty and personal care 6.1 32.4 General merchandise 2.7 20.0 Total turnover 8.6 100.0 Improved performance in second half – up 10% Promotional activity – increased from 23% to 26% of sales, with no margin
Slide 19: Pharmacy
PHARMACY Continued switch to generics +16.1% 40.3% of sales Trend to self-medication OTC medicines +14.1% 223 000 Discovery MedSaver/ HealthyCare members Total volume growth +10.8% Pharmacy staff turnover down from 37% to 28% Market share % 2013 2012 Retail pharmacy* 17.6 16.2 * Per
Slide 20: Front Shop Health
FRONT SHOP HEALTH Good growth in key categories Front shop medicines +12.1% Vitamins and supplements +11.4% Baby +27.6% Broadening product ranges Space increased by 9.6% Market share % 2013 2012 Front shop health** 39.6 38.5 Baby** 9.9 8.4 ** Per AC Nielsen (restated) CLICKS GROUP ANNU
Slide 21: Beauty and Personal Care
BEAUTY AND PERSONAL CARE Highly competitive markets Promotions key to driving sales Fragrance +13.0% Colour cosmetics +6.5% Skincare +6.4% Slower growth in haircare +1.5% Lack of product innovation in Caucasian haircare Market share % 2013 2012 Skincare** 34.4 34.1 Haircare** 30.5 30
Slide 22: General Merchandise
GENERAL MERCHANDISE Improvement in homeware +1.5% Up 3.9% in second half Ranges being refreshed Good performance in convenience categories Confectionery +9.6% Domestics +16.4% Electrical -1.2% impacted by warm winter and focus on margin Market share % 2013 2012 Small household applia
Slide 23: Customers and Stores
CUSTOMERS AND STORES ClubCard membership now 4.1m 76.1% of sales 225 000 members of Baby Club Private label maintained at 18.4% of sales Front shop at 24.1% 54 private label medicines on shelf 331 dispensaries in 442 stores at year end 25 new stores in FY2014 20 – 25 new pharmacies
Slide 24: Musica
MUSICA AWORLD AWAITS
Slide 25: Performance
PERFORMANCE Market share* % change % contribution 2013 2012 CDs (6.5) 44.3 46.2% 43.7% DVDs 2.6 27.3 29.5% 27.7% Gaming (14.7) 14.5 7.3% 9.8% Technology 38.5 13.9 Continued market share gains in CDs and DVDs Reduced focus on lower margin gaming category Good growth in technology Net closure
Slide 26: Performance
PERFORMANCE Higher income customers proving more resilient Good sales performance New skincare and make-up launches Good gifting ranges “Love Your Body” sales up 16.9% Now 58% of sales Capsules in 54 Clicks stores and 9 store-in-store concepts 4 new stores in FY2013, and a further 2
Slide 27: UPD
Slide 28: Turnover
TURNOVER % change % contribution Clicks 9.8 32.0 Hospitals 14.1 25.9 Independent pharmacy (5.6) 18.1 Other channels 334.3 24.0 Total turnover 22.8 100.0 Volume growth of 23.5% Generics +26.7% CLICKS GROUP ANNUAL RESULTS 2013 28
Slide 29: Performance
PERFORMANCE UPD manages total turnover of R11.5 billion 154 million units Significant player in the bulk distribution market Portfolio of 20 distribution clients R3.8bn notional turnover in FY2013 Margin pressure from growth in generics Generics now 36.9% of wholesale medicines Whole
Slide 30: Outlook
OUTLOOK DAVID KNEALE
Slide 31: Outlook
OUTLOOK Muted consumer spending growth to continue Selling price inflation expected to be 4% - 5% Clicks Leverage investment in pharmacy Optimise the ClubCard programme Increase private label penetration Continue to expand store footprint UPD Leverage efficiencies from investment i
Slide 32: Thank You
THANK YOU
Slide 33: Disclaimer
DISCLAIMER Clicks Group has acted in good faith and has made every reasonable effort to ensure the accuracy and completeness of the information contained in this presentation, including all information that may be defined as 'forward-looking statements' within the meaning of United States securities